Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trial

Por Zhao, Yannan, Lv, Fangfang, Chen, She, Wang, Zhonghua, Zhang, Jian, Zhang, Sheng, Cao, Jun, Wang, Leiping, Cao, Enying, Wang, Biyun, Hu, Xichun
Publicado no BMC Cancer (2018)

Dose modification and efficacy of nab-paclitaxel plus gemcitabine vs. gemcitabine for patients with metastatic pancreatic cancer: phase III MPACT trial

Por Scheithauer, Werner, Ramanathan, Ramesh K., Moore, Malcolm, Macarulla, Teresa, Goldstein, David, Hammel, Pascal, Kunzmann, Volker, Liu, Helen, McGovern, Desmond, Romano, Alfredo, Von Hoff, Daniel D.
Publicado no J Gastrointest Oncol (2016)

Randomized, placebo-controlled phase II trial of heat-killed Mycobacterium vaccae (Longcom batch) formulated as an oral pill (V7)

Por Efremenko, Yuri V, Butov, Dmytro A, Prihoda, Natalia D, Zaitzeva, Svetlana I, Yurchenko, Larisa V, Sokolenko, Nina I, Butova, Tetyana S, Stepanenko, Anna L, Kutsyna, Galyna A, Jirathitikal, Vichai, Bourinbaiar, Aldar S
Publicado em 2013

1768. Efficacy and Safety of Switching From Boosted-Protease Inhibitors (bPI) Plus Emtricitabine...

Por Eron, Joseph, Orkin, Chloe, Cunningham, Douglas, Pulido, Federcio, Post, Frank, De Wit, Stéphane, Lathouwers, Erkki, Hufkens, Veerle, Petrovic, Romana, Landuyt, Erika Van
Publicado no Open Forum Infect Dis (2018)

Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate Cancer

Por Emmenegger, Urban, Booth, Christopher M., Berry, Scott, Sridhar, Srikala S., Winquist, Eric, Bandali, Nesan, Chow, Annabelle, Lee, Christina, Xu, Ping, Man, Shan, Kerbel, Robert S., Ko, Yoo-Joung
Publicado no Oncologist (2015)

Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study

Por Hara, Ryoki, Umebayashi, Hiroaki, Takei, Syuji, Okamoto, Nami, Iwata, Naomi, Yamasaki, Yuichi, Nakagishi, Yasuo, Kizawa, Toshitaka, Kobayashi, Ichiro, Imagawa, Tomoyuki, Kinjo, Noriko, Amano, Norihito, Takahashi, Yoko, Mori, Masaaki, Itoh, Yasuhiko, Yokota, Shumpei
Publicado no Pediatr Rheumatol Online J (2019)

Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study

Por Ryoki Hara, Hiroaki Umebayashi, Syuji Takei, Nami Okamoto, Naomi Iwata, Yuichi Yamasaki, Yasuo Nakagishi, Toshitaka Kizawa, Ichiro Kobayashi, Tomoyuki Imagawa, Noriko Kinjo, Norihito Amano, Yoko Takahashi, Masaaki Mori, Yasuhiko Itoh, Shumpei Yokota
Publicado em 2019-04-01

ACTR-12. PHASE 2 STUDY OF DIANHYDROGALACTITOL (VAL-083) IN PATIENTS WITH MGMT-UNMETHYLATED...

Por O’Brien, Barbara, Penas-Prado, Marta, Kamiya, Carolos, Pei Weathers, Shiao-, Yung, Alfred, Loghin, Monica, Harrison, Rebecca, Bacha, Jeffrey, Brown, Dennis, Johnson, Gregory, Langlands, John, Schwartz, Richard, Kanekal, Sarath, Lopez, Lorena, deGroot, John
Publicado no Neuro Oncol (2019)

Phase II Study of Rabbit Anti-Thymocyte Globulin, Cyclosporine, and Granulocyte Colony Stimulating...

Por Garg, Ravin, Faderl, Stefan, Garcia-Manero, Guillermo, Cortes, Jorge, Koller, Charles, Huang, Xuelin, York, Sergerne, Pierce, Sherry, Brandt, Mark, Beran, Miloslav, Borthakur, Gautam, Kantarjian, Hagop, Ravandi, Farhad
Publicado em 2009

Phase II multicentre randomised study of docetaxel plus epirubicin vs 5-fluorouracil plus epirubicin and cyclophosphamide in metastatic breast cancer

Por Bonneterre, J, Dieras, V, Tubiana-Hulin, M, Bougnoux, P, Bonneterre, M-E, Delozier, T, Mayer, F, Culine, S, Dohoulou, N, Bendahmane, B
Publicado em 2004

A phase III randomised controlled trial of erlotinib vs gefitinib in advanced non-small cell lung cancer with EGFR mutations

Por Yang, J J, Zhou, Q, Yan, H H, Zhang, X C, Chen, H J, Tu, H Y, Wang, Z, Xu, C R, Su, J, Wang, B C, Jiang, B Y, Bai, X Y, Zhong, W Z, Yang, X N, Wu, Y L
Publicado no Br J Cancer (2017)

Week 48 Results of EMERALD: A Phase 3, Randomized, Non-inferiority Study Evaluating the Efficacy...

Por Orkin, Chloe, Molina, Jean-Michel, Gallant, Joel, Negredo, Eugenia, Gathe, Joseph, Eron, Joseph, Van Landuyt, Erika, Lathouwers, Erkki, Hufkens, Veerle, Petrovic, Romana, Opsomer, Magda
Publicado no Open Forum Infect Dis (2017)

Laparoscopic versus open gastrectomy for elderly local advanced gastric cancer patients: study protocol of a phase II randomized controlled trial

Por Li, Ziyu, Shan, Fei, Ying, Xiangji, Xue, Kan, Ji, Jiafu
Publicado no BMC Cancer (2018)

Clinical trial protocol of doublet therapy and olanzapine for carboplatin-induced nausea and vomiting in patients with thoracic cancer: a multicentre phase II trial

Por Iihara, Hirotoshi, Shimokawa, Mototsugu, Gomyo, Takenobu, Fujita, Yukiyoshi, Yoshida, Tsutomu, Funaguchi, Norihiko, Minato, Koichi, Kaito, Daizo, Osawa, Tomohiro, Yamada, Momoko, Hirose, Chiemi, Suzuki, Akio, Ohno, Yasushi
Publicado no BMJ Open (2019)

A multicenter phase 4 geriatric assessment directed trial to evaluate gemcitabine +/− nab-paclitaxel in elderly pancreatic cancer patients (GrantPax)

Por Betge, Johannes, Chi-Kern, Jing, Schulte, Nadine, Belle, Sebastian, Gutting, Tobias, Burgermeister, Elke, Jesenofsky, Ralf, Maenz, Martin, Wedding, Ulrich, Ebert, Matthias P., Haertel, Nicolai
Publicado no BMC Cancer (2018)

A Phase II Randomised Controlled Trial Adding Oral Flucytosine to High Dose Fluconazole, with Short-course Amphotericin B, for Cryptococcal Meningitis

Por Jackson, A, Nussbaum, J, Phulusa, J, Namarika, D, Chikasema, M, Kenyemba, C, Jarvis, JN, Jaffar, S, Hosseinipour, MC, van der Horst, C, Harrison, TS
Publicado em 2012

Simeprevir plus sofosbuvir in patients with chronic hepatitis C virus genotype 1 infection and cirrhosis: A phase 3 study (OPTIMIST‐2)

Por Lawitz, Eric, Matusow, Gary, DeJesus, Edwin, Yoshida, Eric M., Felizarta, Franco, Ghalib, Reem, Godofsky, Eliot, Herring, Robert W., Poleynard, Gary, Sheikh, Aasim, Tobias, Hillel, Kugelmas, Marcelo, Kalmeijer, Ronald, Peeters, Monika, Lenz, Oliver, Fevery, Bart, De La Rosa, Guy, Scott, Jane, Sinha, Rekha, Witek, James
Publicado no Hepatology (2016)

A phase 2 study of the combination of gemcitabine and cisplatin in patients with locally advanced...

Por Hanna Kohail, Samir Shehata, Omar Mansour, Youssri Gouda, Rabbab Gaafar, Thoraya Abdel Hamid, Saiid El Nowieam, Ahmed Al Khodary, Heba El Zawahry, Ahmed Abdel Wareth, Iman Abdel Halim, Fouad Abou Taleb, Emad Hamada, Mohsen Barsoum, Mohamed Abdullah, Mohamed Meshref
Publicado em 2012-01-01

Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study

Por Wyles, David, Bräu, Norbert, Kottilil, Shyam, Daar, Eric S, Ruane, Peter, Workowski, Kimberly, Luetkemeyer, Anne, Adeyemi, Oluwatoyin, Kim, Arthur Y, Doehle, Brian, Huang, K C, Mogalian, Erik, Osinusi, Anu, McNally, John, Brainard, Diana M, McHutchison, John G, Naggie, Susanna, Sulkowski, Mark
Publicado no Clin Infect Dis (2017)

A randomized phase II trial of 5-day versus 10-day schedules of decitabine in older patients with newly diagnosed acute myeloid leukemia

Por Short, Nicholas J., Kantarjian, Hagop M., Loghavi, Sanam, Huang, Xuelin, Qiao, Wei, Borthakur, Gautam, Kadia, Tapan M., Daver, Naval, Ohanian, Maro, Dinardo, Courtney D., Estrov, Zeev, Kanagal-Shamanna, Rashmi, Maiti, Abhishek, Benton, Christopher B., Bose, Prithviraj, Alvarado, Yesid, Jabbour, Elias, Kornblau, Steven M., Pemmaraju, Naveen, Jain, Nitin, Gasior, Yvonne, Richie, Mary Ann, Pierce, Sherry, Cortes, Jorge, Konopleva, Marina, Garcia-Manero, Guillermo, Ravandi, Farhad
Publicado no Lancet Haematol (2018)